0.00Open82.70Pre Close0 Volume0 Open Interest160.00Strike Price0.00Turnover2856.29%IV-3.97%PremiumAug 16, 2024Expiry Date92.74Intrinsic Value100Multiplier-7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9919Delta0.0005Gamma3.06Leverage Ratio-28.4768Theta0.0001Rho3.03Eff Leverage0.0004Vega
Madrigal Pharmaceuticals Stock Discussion
MDGL gained as much as 15.2% to a $294.44 intraday high after Wolfe lauded the company's breakthrough liver drug Rezdiffra, according to published reports.
The U.S. Food and Drug Administration approved Rezdiffra in March as the first treatment fornonalcoholic steatoh...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$